Second time’s a charm for PharmaEssentia as FDA approves Besremi to treat rare blood cancernews2021-11-15T14:16:25+00:00November 15th, 2021|Fierce Pharma|
After triggering a global valsartan recall 3 years ago, Chinese drug manufacturer overcomes FDA warning letternews2021-11-15T11:43:21+00:00November 15th, 2021|Fierce Pharma|
Rapper Common encourages lung cancer screenings, clinical trials for Black community in Bristol Myers-backed PSAnews2021-11-15T01:55:10+00:00November 15th, 2021|Fierce Pharma|
Utah Jazz rookie Jared Butler opens up about heart diagnosis in new Bristol Myers Squibb awareness campaignnews2021-11-12T22:06:28+00:00November 12th, 2021|Fierce Pharma|
GlaxoSmithKline, Vir target emergency authorization for intramuscular COVID-19 antibody drug with new trial winnews2021-11-12T16:43:21+00:00November 12th, 2021|Fierce Pharma|
AstraZeneca’s star China business slows on Tagrisso price cut, but Alexion may come to the rescuenews2021-11-12T15:02:22+00:00November 12th, 2021|Fierce Pharma|
Johnson & Johnson to spin out consumer health business in new publicly traded companynews2021-11-12T12:48:54+00:00November 12th, 2021|Fierce Pharma|
Fierce Pharma Asia—Takeda’s Alunbrig pricing pact; Merck, Japan COVID pill deal; SK Biopharm’s Chinese JVnews2021-11-12T09:52:41+00:00November 12th, 2021|Fierce Pharma|
AstraZeneca’s latest heart awareness campaign with fitness guru Bob Harper showcases his passion for photographynews2021-11-12T09:28:22+00:00November 12th, 2021|Fierce Pharma|
Late to the party: Europe on the verge of approving Roche and Celltrion antibodies for COVIDnews2021-11-11T22:31:45+00:00November 11th, 2021|Fierce Pharma|
